Epizyme, Inc. (EPZM): Price and Financial Metrics


Epizyme, Inc. (EPZM): $1.47

-0.01 (-0.68%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EPZM to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

EPZM POWR Grades


  • Growth is the dimension where EPZM ranks best; there it ranks ahead of 74.06% of US stocks.
  • The strongest trend for EPZM is in Stability, which has been heading down over the past 179 days.
  • EPZM's current lowest rank is in the Stability metric (where it is better than 2.38% of US stocks).

EPZM Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for EPZM is -1.81 -- better than merely 3.47% of US stocks.
  • As for revenue growth, note that EPZM's revenue has grown 137.45% over the past 12 months; that beats the revenue growth of 94.26% of US companies in our set.
  • In terms of volatility of its share price, EPZM is more volatile than 97.4% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Epizyme Inc, a group of peers worth examining would be KMPH, ALBO, KPTI, RDUS, and BYSI.
  • EPZM's SEC filings can be seen here. And to visit Epizyme Inc's official web site, go to www.epizyme.com.

EPZM Valuation Summary

  • In comparison to the median Healthcare stock, EPZM's price/sales ratio is 326.32% higher, now standing at 16.2.
  • EPZM's EV/EBIT ratio has moved up 191.6 over the prior 100 months.
  • EPZM's price/sales ratio has moved up 3.5 over the prior 100 months.

Below are key valuation metrics over time for EPZM.

Stock Date P/S P/B P/E EV/EBIT
EPZM 2021-08-31 16.2 7.8 -2.1 -2.8
EPZM 2021-08-30 15.6 7.5 -2.0 -2.7
EPZM 2021-08-27 15.7 7.6 -2.0 -2.8
EPZM 2021-08-26 15.3 7.3 -1.9 -2.7
EPZM 2021-08-25 15.6 7.5 -2.0 -2.8
EPZM 2021-08-24 15.4 7.4 -1.9 -2.7

EPZM Growth Metrics

    Its 4 year cash and equivalents growth rate is now at -42.66%.
  • Its year over year net income to common stockholders growth rate is now at -30.82%.
  • Its year over year cash and equivalents growth rate is now at -58.88%.
EPZM's revenue has moved up $7,836,000 over the prior 34 months.

The table below shows EPZM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 37.427 -226.853 -251.122
2021-09-30 34.217 -228.002 -266.704
2021-06-30 32.582 -227.886 -256.943
2021-03-31 22.039 -223.643 -251.031
2020-12-31 15.762 -206.336 -231.694
2020-09-30 11.681 -188.705 -221.863

EPZM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EPZM has a Quality Grade of D, ranking ahead of 24.13% of graded US stocks.
  • EPZM's asset turnover comes in at 0.081 -- ranking 279th of 681 Pharmaceutical Products stocks.
  • MTEX, VTVT, and ADXS are the stocks whose asset turnover ratios are most correlated with EPZM.

The table below shows EPZM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.081 0.731 -0.584
2021-03-31 0.052 0.668 -0.620
2020-12-31 0.036 0.679 -0.669
2020-09-30 0.028 0.722 -0.731
2020-06-30 0.034 0.882 -0.713
2020-03-31 0.044 0.964 -0.691

EPZM Price Target

For more insight on analysts targets of EPZM, see our EPZM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.50 Average Broker Recommendation 1.57 (Moderate Buy)

EPZM Stock Price Chart Interactive Chart >

Price chart for EPZM

EPZM Price/Volume Stats

Current price $1.47 52-week high $7.94
Prev. close $1.48 52-week low $0.41
Day low $1.47 Volume 4,096
Day high $1.47 Avg. volume 3,214,829
50-day MA $0.72 Dividend yield N/A
200-day MA $2.27 Market Cap 242.37M

Epizyme, Inc. (EPZM) Company Bio


Epizyme, Inc. discovers and develops epigenetic therapies for cancer patients. The company was founded in 2007 and is based in Cambridge, Massachusetts.


EPZM Latest News Stream


Event/Time News Detail
Loading, please wait...

EPZM Latest Social Stream


Loading social stream, please wait...

View Full EPZM Social Stream

Latest EPZM News From Around the Web

Below are the latest news stories about Epizyme Inc that investors may wish to consider to help them evaluate EPZM as an investment opportunity.

Epizyme Announces Date of Fourth Quarter and Full Year 2021 Financial Results

CAMBRIDGE, Mass., February 22, 2022--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that management will host a conference call to discuss its fourth quarter and full year 2021 financial results and provide a business update on Tuesday, March 1, 2022 at 8:30 a.m. ET.

Yahoo | February 22, 2022

Is a Surprise Coming for Epizyme (EPZM) This Earnings Season?

Epizyme (EPZM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | February 17, 2022

Epizyme (EPZM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Epizyme (EPZM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 15, 2022

Why Shares of Epizyme Soared 32.1% This Week

The small biopharmaceutical company bounced back after its shares lost half their value the week before.

The Motley Fool | February 3, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, investor!

William White on InvestorPlace | February 2, 2022

Read More 'EPZM' Stories Here

EPZM Price Returns

1-mo 183.24%
3-mo 40.00%
6-mo -34.96%
1-year N/A
3-year -89.00%
5-year -90.07%
YTD -41.20%
2021 -76.98%
2020 -55.85%
2019 299.35%
2018 -50.92%
2017 3.72%

Continue Researching EPZM

Want to see what other sources are saying about Epizyme Inc's financials and stock price? Try the links below:

Epizyme Inc (EPZM) Stock Price | Nasdaq
Epizyme Inc (EPZM) Stock Quote, History and News - Yahoo Finance
Epizyme Inc (EPZM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6379 seconds.